Connective tissue growth factor antibodies
US7405274B2 · kind B2 · utility
23Cited by
3References
28Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 1, 2004 |
| Grant date | Jul 29, 2008 |
| Priority date | — |
| Expiry date | Apr 18, 2025 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2317/92
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to antibodies that bind to CTGF. The antibodies are particularly directed to regions of CTGF involved in biological activities associated with fibrosis. The invention also relates to methods of using the antibodies to treat disorders associated with CTGF including localized and systemic fibrotic disorders including those of the lung, liver, heart, skin, and kidney.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.